Lv6
2700 积分 2021-02-23 加入
FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions
23天前
已完结
Ripretinib and MEK Inhibitors Synergize to Induce Apoptosis in Preclinical Models of GIST and Systemic Mastocytosis
26天前
已关闭
Sustained Tumor Control With MAPK Inhibition in BRAF V600–Mutant Adult Glial and Glioneuronal Tumors
1个月前
已完结
BRAF-Driven Pancreatic Cancer: Prevalence, Molecular Features, and Therapeutic Opportunities
2个月前
已完结
5’UTR gene regions in germline DNA sequencing panels: lessons from the analysis of breast and ovarian cancer patients of Tatar and Bashkir ethnic origin
2个月前
已完结
Novel germline TP53 variant (p.(Phe109Ile)) confer high risk of cancer
3个月前
已关闭
Genetic background of FH: Variants of uncertain clinical significance in severe FH phenotype
3个月前
已关闭
Open-Label, Multicenter, Phase I/II, First-in-Human Trial of TK216: A First-Generation EWS::FLI1 Fusion Protein Antagonist in Ewing Sarcoma
4个月前
已完结
Clinical findings in 39 individuals with Bohring–Opitz syndrome from a global patient‐driven registry with implications for tumor surveillance and recurrence risk
4个月前
已完结
皖公网安备34019202002308
